Who Paid My Doc
Michael Coughlin
Foot and Ankle Surgery San Francisco, CA Medical Doctor
NPI 1023010824 CMS profile 91642
400 Parnassus Ave, San Francisco, CA 94143
General payments
$1,592,452
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$21,020
Through program year 2025, Michael Coughlin of San Francisco, CA is reported in the CMS Open Payments database as having received $1,592,452 across 260 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $21,020 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $175,233 | 13 | |
| 2024 | General | $279,604 | 30 | |
| 2023 | General | $139,560 | 13 | |
| 2022 | General | $248,815 | 29 | |
| 2021 | General | $244,643 | 51 | |
| 2020 | General | $231,531 | 48 | |
| 2019 | General | $273,067 | 76 |
Beside peers
- Michael Coughlin
- Foot and Ankle Surgery median
- Middle half of Foot and Ankle Surgery
- National median
In program year 2025, general payments to Michael Coughlin were reported at $175,233. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.
Show as a table
| Year | Michael Coughlin | Foot and Ankle Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $273,067 | $1,327 | $279–$5,421 | $163 |
| 2020 | $231,531 | $795 | $121–$3,473 | $114 |
| 2021 | $244,643 | $1,289 | $201–$4,963 | $132 |
| 2022 | $248,815 | $1,539 | $270–$6,067 | $149 |
| 2023 | $139,560 | $1,117 | $257–$5,264 | $160 |
| 2024 | $279,604 | $1,064 | $235–$4,944 | $164 |
| 2025 | $175,233 | $1,183 | $267–$6,309 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
260 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Foot and Ankle Surgery in California
Eric Giza
Foot and Ankle Surgery · Sacramento, CA
Thomas Harris
Foot and Ankle Surgery · Pasadena, CA
Candice Brady
Foot and Ankle Surgery · Camarillo, CA
Andrew Hsu
Foot and Ankle Surgery · Orange, CA
Eric Tan
Foot and Ankle Surgery · Los Angeles, CA
David Oji
Foot and Ankle Surgery · Los Gatos, CA
Related records
Foot and Ankle Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Foot and Ankle Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.